Previous Article | Next Article ![]()
Infection and Immunity, March 2000, p. 1408-1417, Vol. 68, No. 3
Max von Pettenkofer-Institut für
Hygiene und Medizinische Mikrobiologie1 and
Pathologisches Institut,2
Ludwig-Maximilians-Universität, Munich, and
Forschungsinstitut für Molekulare Pharmakologie,
Abteilung für Molekulare Genetik, Berlin,3
Germany
Received 13 September 1999/Returned for modification 19 October
1999/Accepted 30 November 1999
Interferon consensus sequence binding protein (ICSBP)-deficient
mice display enhanced susceptibility to intracellular pathogens. At
least two distinct immunoregulatory defects are responsible for this
phenotype. First, diminished production of reactive oxygen intermediates in macrophages results in impaired intracellular killing
of microorganisms. Second, defective early interleukin-12 (IL-12)
production upon microbial challenge leads to a failure in gamma
interferon (IFN-
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Interferon Consensus Sequence Binding Protein
Confers Resistance against Yersinia enterocolitica

) induction and subsequently in T helper 1 immune
responses. Here, we investigated the role of ICSBP in resistance
against the extracellular bacterium Yersinia
enterocolitica. ICSBP
/
mice failed to produce
IL-12 and IFN-
, but also IL-4, after Yersinia challenge.
In addition, granuloma formation was highly disturbed in infected
ICSBP
/
mice, leading to multiple necrotic abscesses in
affected organs. Consequently, ICSBP
/
mice rapidly
succumbed to acute Yersinia infection. In vitro treatment
of spleen cells from ICSBP
/
mice with recombinant IL-12
(rIL-12) or rIL-18 in combination with a second stimulus resulted in
IFN-
induction. In experimental therapy of infected
ICSBP
/
mice, we observed that administration of rIL-12
induced IFN-
production which was associated with improved
resistance to Yersinia. In contrast, treatment with rIL-18
failed to enhance endogenous IFN-
production but nevertheless
reduced bacterial burden in ICSBP
/
mice. Although
cytokine therapy with rIL-12 or rIL-18 ameliorated the course of
Yersinia infection in ICSBP
/
mice, both
cytokines failed to completely restore impaired immunity. Taken
together, the results indicate that the transcription factor ICSBP is
essential for efficient host immune defense against
Yersinia. These results are important for understanding the
complex host immune responses in bacterial infections.
*
Corresponding author. Mailing address: Max von
Pettenkofer-Institut, Ludwig-Maximilians-Universität
München, Pettenkoferstrasse 9a, D-80336 Munich, Germany.
Phone: 49-89-5160-5280. Fax: 49-89-5160-5223. E-mail:
autenrieth{at}m3401.mpk.med.uni-muenchen.de.
Present address: Institut für Klinische Mikrobiologie,
Immunologie und Hygiene, Friedrich-Alexander Universität
Erlangen-Nürnberg, D-91054 Erlangen, Germany.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»